查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1877786

2025年全球体外癌症诊断市场报告

In Vitro Cancer Diagnostics Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，体外癌症诊断市场规模显着成长，预计将从2024年的106.8亿美元成长到2025年的114.9亿美元，复合年增长率（CAGR）为7.5%。过去几年的增长可归因于癌症发病率的上升、患者对癌症早期检测意识的增强、分子诊断技术的日益普及、医疗基础设施投资的增加以及对癌症诊断生物标誌物发现研究的日益重视。

预计未来几年体外癌症诊断市场规模将强劲成长，2029年将达到155.4亿美元，复合年增长率（CAGR）为7.8%。预测期内的成长将主要受以下因素驱动：肿瘤学领域对个人化医疗的需求不断增长、照护现场癌症诊断需求不断增长、人们对微创检测方法的认识不断提高、对生物技术和诊断Start-Ups的投资不断增加，以及对经济高效的诊断解决方案的需求不断增长。预测期内的关键趋势包括液态生物检体技术的进步、与人工智慧的融合、微流体平台的创新、数位病理系统的发展以及基因组数据分析的进步。

预计未来几年，液态生物检体技术的日益普及将推动体外癌症诊断市场的成长。液态生物检体技术是一种微创诊断方法，它能够检测和分析存在于血液、尿液和唾液等体液中的生物标记物，例如循环肿瘤DNA、循环性肿瘤细胞和外泌体，从而监测疾病（尤其是癌症）的存在、进展和治疗反应。从血液和其他体液中分离和分析循环肿瘤DNA和循环性肿瘤细胞的技术进步促进了液态生物检体技术的扩展。液态生物检体技术的快速普及正在推动对体外癌症诊断解决方案的需求，因为用于癌症检测和治疗指导的非侵入性即时分子分析工具正被越来越多地采用。例如，据英国国家医疗服务体系（NHS England）称，到2025年5月，英国新推出的液态生物检体血液检测预计每年将使多达15,000名疑似肺癌患者和5,000名进行性乳癌女性患者受益。预计检测对象数量将从2025年初推出时的约2,200人增加到2028年的每年约20,000人。因此，液态生物检体技术的日益普及正在推动体外癌症诊断市场的成长。

体外癌症诊断市场的主要企业正致力于开发人工智慧驱动的癌症诊断技术，旨在改善患者预后并促进个人化医疗。人工智慧驱动的癌症诊断利用人工智慧分析从患者检体、影像和基因检测中获得的医学和分子数据，从而实现高度精准的癌症检测、诊断和预测。例如，总部位于瑞士的製药公司罗氏于2024年9月推出了数位病理开放环境（Digital Pathology Open Environment），这是一个协作平台，安全地整合了罗氏和多家第三方开发商的先进人工智慧影像分析工具。该平台使病理学家能够存取罗氏Navifify数位病理企业软体中的创新演算法，从而提高诊断准确性和工作流程效率。透过促进协作和数据共用，该平台加速了癌症诊断和监测领域的创新，支持精准医疗，实现了更有效的标靶治疗，并扩大了全球先进数位病理解决方案的获取途径。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税，以及新冠疫情及其復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球体外癌症诊断市场：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
  • 终端用户产业分析
  • 全球体外癌症诊断市场：成长率分析
  • 全球体外癌症诊断市场表现：规模与成长，2019-2024年
  • 全球体外癌症诊断市场预测：规模与成长，2024-2029年，2034年预测
  • 全球体外癌症诊断市场：潜在市场规模（TAM）

第六章 市场细分

  • 全球体外癌症诊断市场：依产品类型、效能和预测划分，2019-2024年、2024-2029年预测、2034年预测
  • 成套工具
  • 装置
  • 试剂
  • 软体
  • 消耗品
  • 全球体外癌症诊断市场：依技术、效能和预测划分，2019-2024年、2024-2029年预测、2034年预测
  • 聚合酵素链锁反应（PCR）
  • 次世代定序（NGS）
  • 萤光原位杂合反应（FISH）
  • 免疫组织化学
  • 其他技术
  • 全球体外癌症诊断市场：依应用、效能和预测划分，2019-2024年、2024-2029年预测、2034年预测
  • 乳癌
  • 肺癌
  • 大肠直肠癌
  • 摄护腺癌
  • 其他用途
  • 全球体外癌症诊断市场：依最终用户、效能和预测划分，2019-2024年、2024-2029年预测、2034年预测
  • 医院
  • 诊断检查室
  • 研究所
  • 居家医疗环境
  • 其他最终用户
  • 全球体外癌症诊断市场：依试剂盒、类型、效能和预测细分，2019-2024年、2024-2029年预测、2034年预测
  • 免疫检测盒
  • 聚合酵素链锁反应(PCR) 试剂盒
  • 酵素免疫分析法（ELISA）试剂盒
  • 流式细胞技术盒
  • 全球体外癌症诊断市场：按设备、类型、性能和预测进行细分，2019-2024年、2024-2029年预测、2034年预测
  • 聚合酵素链锁反应（PCR）设备
  • 序列器
  • 流式细胞仪
  • 影像系统
  • 全球体外癌症诊断市场：依试剂、类型、效能和预测细分，2019-2024年、2024-2029年预测、2034年预测
  • 酵素
  • 缓衝
  • 探测
  • 染料
  • 全球体外癌症诊断市场：依软体、类型、效能和预测细分，2019-2024年、2024-2029年预测、2034年预测
  • 数据分析软体
  • 影像处理软体
  • 实验室资讯管理系统（LIMS）软体
  • 诊断报告软体
  • 全球体外癌症诊断市场：按耗材、类型、性能和预测细分，2019-2024年、2024-2029年预测、2034年预测
  • 微孔盘
  • 微量吸管尖
  • 管子
  • 滑动

第七章 区域和国家分析

  • 全球体外癌症诊断市场：依地区、绩效及预测划分，2019-2024年、2024-2029年预测、2034年预测
  • 全球体外癌症诊断市场：依国家、绩效及预测划分，2019-2024 年、2024-2029 年预测、2034 年预测

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第十八章：法国市场

第十九章：义大利市场

第二十章：西班牙市场

第21章 东欧市场

第22章：俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第三十章：竞争格局与公司概况

  • 体外癌症诊断市场：竞争格局
  • 体外癌症诊断市场：公司概况
    • F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
    • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Overview, Products and Services, Strategy and Financial Analysis
    • Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • Illumina Inc
  • Hologic Inc
  • Qiagen NV
  • Bio-Rad Laboratories Inc
  • Agilent Technologies
  • Becton Dickinson and Company（BD）
  • Sysmex Corporation
  • LabCorp Holding Corp.
  • Guardant Health
  • Quest Diagnostics
  • Exact Sciences
  • Myriad Genetics Inc
  • Natera Inc.
  • NeoGenomics Laboratories
  • NanoString Technologies Inc

第32章 全球市场竞争基准化分析与仪錶板

第33章 重大併购

第34章 近期市场趋势

第35章：高潜力市场国家、细分市场与策略

  • 2029年体外癌症诊断市场：提供新机会的国家
  • 2029年体外癌症诊断市场：新兴细分市场机会
  • 2029年体外癌症诊断市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章附录

简介目录
Product Code: r39261

In vitro cancer diagnostics refers to laboratory-based tests conducted on samples such as blood, tissue, or other body fluids to detect, monitor, or evaluate cancer outside the human body. These diagnostics employ techniques like molecular assays, biomarker analysis, and genetic profiling to identify the presence or progression of cancer. They support early detection, accurate diagnosis, and informed treatment planning for patients.

The key product types in in vitro cancer diagnostics include kits, instruments, reagents, software, and consumables. Kits are ready-to-use sets of reagents and materials designed for diagnostic testing, enabling biomarker detection, supporting disease monitoring, and assisting in treatment evaluation. Technologies used include polymerase chain reaction (PCR), next-generation sequencing (NGS), fluorescence in situ hybridization (FISH), immunohistochemistry, and others. These diagnostics are applied across multiple cancer types, including breast cancer, lung cancer, colorectal cancer, and prostate cancer, and serve end users such as hospitals, diagnostic laboratories, research institutes, home care settings, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The in vitro cancer diagnostics market research report is one of a series of new reports from The Business Research Company that provides in vitro cancer diagnostics market statistics, including in vitro cancer diagnostics industry global market size, regional shares, competitors with a in vitro cancer diagnostics market share, detailed in vitro cancer diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the in vitro cancer diagnostics industry. This in vitro cancer diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The in vitro cancer diagnostics market size has grown strongly in recent years. It will grow from $10.68 billion in 2024 to $11.49 billion in 2025 at a compound annual growth rate (CAGR) of 7.5%. The growth observed during the historical period can be attributed to the rising prevalence of cancer, heightened awareness among patients regarding early cancer detection, increased adoption of molecular diagnostic techniques, expanded investments in healthcare infrastructure, and a growing focus on research in biomarker discovery for cancer diagnostics.

The in vitro cancer diagnostics market size is expected to see strong growth in the next few years. It will grow to $15.54 billion in 2029 at a compound annual growth rate (CAGR) of 7.8%. The growth during the forecast period is driven by the increasing demand for personalized medicine in oncology, rising demand for point-of-care cancer diagnostics, growing awareness of minimally invasive testing methods, increasing investment in biotech and diagnostic startups, and rising need for cost-effective diagnostic solutions. Primary trends in the forecast period include advancements in liquid biopsy technology, integration with artificial intelligence, innovation in microfluidics platforms, development of digital pathology systems, and progress in genomic data analysis.

The rising adoption of liquid biopsy technologies is expected to enhance the growth of the in vitro cancer diagnostics market in the coming years. Liquid biopsy technologies refer to minimally invasive diagnostic methods that detect and analyze biomarkers such as circulating tumor DNA, circulating tumor cells, or exosomes present in body fluids like blood, urine, or saliva to monitor disease presence, progression, or response to treatment, particularly in cancer. The use of liquid biopsy technologies is increasing due to advancements in isolating and analyzing circulating tumor DNA and circulating tumor cells from blood and other body fluids. In vitro cancer diagnostic solutions are experiencing higher demand as the rapid adoption of liquid biopsy technologies encourages companies to implement non invasive and real time molecular profiling tools for cancer detection and treatment guidance. For example, in May 2025, according to NHS England, a UK based public healthcare system, the new liquid biopsy blood test rollout in the UK is expected to benefit up to 15,000 patients with suspected lung cancer and 5,000 women with advanced breast cancer annually, expanding from about 2,200 patients tested during the early 2025 rollout to an estimated 20,000 patients per year by 2028. Therefore, the rising adoption of liquid biopsy technologies is enhancing the growth of the in vitro cancer diagnostics market.

Leading companies operating in the in vitro cancer diagnostics market are emphasizing the development of AI-driven cancer diagnostics to improve patient outcomes and advance personalized healthcare. AI-driven cancer diagnostics involve the use of artificial intelligence to analyze medical and molecular data from patient samples, imaging, or genetic tests, enabling highly accurate detection, diagnosis, and prediction of cancer. For instance, in September 2024, Roche, a Switzerland-based pharmaceutical company, introduced the Digital Pathology Open Environment, a collaborative platform that securely integrates advanced AI-based image analysis tools from Roche and multiple third-party developers. The platform allows pathologists to access innovative algorithms within Roche's Navify Digital Pathology enterprise software, enhancing diagnostic precision and workflow efficiency. By fostering collaboration and data sharing, the platform accelerates innovation in cancer diagnostics and research, supports precision medicine, and enables more effective targeted treatments, expanding global access to advanced digital pathology solutions.

In February 2024, Veracyte Inc., a US-based molecular diagnostics company, acquired C2i Genomics, Inc. for an undisclosed amount. Through this acquisition, Veracyte aims to expand its presence across the cancer care continuum by incorporating AI-driven whole-genome minimal residual disease testing to enhance treatment monitoring and detect disease recurrence. C2i Genomics Inc. is a US-based biotechnology company that provides in vitro cancer diagnostics.

Major players operating in the in vitro cancer diagnostics market are F. Hoffmann-La Roche Ltd, Danaher Corporation, Abbott Laboratories, Thermo Fisher Scientific, Siemens Healthineers AG, Illumina Inc, Hologic Inc, Qiagen N.V, Bio-Rad Laboratories Inc, Agilent Technologies, Becton, Dickinson and Company (BD), Sysmex Corporation, LabCorp Holding Corp., Guardant Health, Quest Diagnostics, Exact Sciences, Myriad Genetics Inc, Natera Inc., NeoGenomics Laboratories, NanoString Technologies Inc, Caris Life Sciences, Transasia Bio-Medicals Ltd, Autobio Diagnostics Co Ltd, QuidelOrtho Corporation, Cancer Diagnostics Inc, Predicine Inc, Strata Oncology, Biocept Inc, Lucence Diagnostics

North America was the largest region in the in vitro cancer diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the in vitro cancer diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the in vitro cancer diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The in vitro cancer diagnostics market consists of revenues earned by entities by providing services such as molecular diagnostic testing, biopsy and cytology analysis, companion diagnostic services, and next-generation sequencing (NGS) services. The market value includes the value of related goods sold by the service provider or included within the service offering. The in vitro cancer diagnostics market also includes sales of cancer biomarker kits, molecular diagnostic assays, flow cytometry kits, tissue-based diagnostic kits, and genomic testing panels. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

In Vitro Cancer Diagnostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on in vitro cancer diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for in vitro cancer diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The in vitro cancer diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product Type: Kits; Instruments; Reagents; Software; Consumables
  • 2) By Technology: Polymerase Chain Reaction (PCR); Next-Generation Sequencing (NGS); Fluorescence In Situ Hybridization (FISH); Immunohistochemistry; Other Technologies
  • 3) By Application: Breast Cancer; Lung Cancer; Colorectal Cancer; Prostate Cancer; Other Applications
  • 4) By End User: Hospitals; Diagnostic Laboratories; Research Institutes; Home Care Settings; Other End Users
  • Subsegments:
  • 1) By Kits: Immunoassay Kits; Polymerase Chain Reaction (PCR) Kits; Enzyme-Linked Immunosorbent Assay (ELISA) Kits; Flow Cytometry Kits
  • 2) By Instruments: Polymerase Chain Reaction (PCR) Instruments; Sequencers; Flow Cytometers; Imaging Systems
  • 3) By Reagents: Enzymes; Buffers; Probes; Stains
  • 4) By Software: Data Analysis Software; Imaging Software; Laboratory Information Management System (LIMS) Software; Diagnostic Reporting Software
  • 5) By Consumables: Microplates; Pipette Tips; Tubes; Slides
  • Companies Mentioned: F. Hoffmann-La Roche Ltd, Danaher Corporation, Abbott Laboratories, Thermo Fisher Scientific, Siemens Healthineers AG, Illumina Inc, Hologic Inc, Qiagen N.V, Bio-Rad Laboratories Inc, Agilent Technologies, Becton, Dickinson and Company (BD), Sysmex Corporation, LabCorp Holding Corp., Guardant Health, Quest Diagnostics, Exact Sciences, Myriad Genetics Inc, Natera Inc., NeoGenomics Laboratories, NanoString Technologies Inc, Caris Life Sciences, Transasia Bio-Medicals Ltd, Autobio Diagnostics Co Ltd, QuidelOrtho Corporation, Cancer Diagnostics Inc, Predicine Inc, Strata Oncology, Biocept Inc, Lucence Diagnostics
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. In Vitro Cancer Diagnostics Market Characteristics

3. In Vitro Cancer Diagnostics Market Trends And Strategies

4. In Vitro Cancer Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global In Vitro Cancer Diagnostics Growth Analysis And Strategic Analysis Framework

  • 5.1. Global In Vitro Cancer Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global In Vitro Cancer Diagnostics Market Growth Rate Analysis
  • 5.4. Global In Vitro Cancer Diagnostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global In Vitro Cancer Diagnostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global In Vitro Cancer Diagnostics Total Addressable Market (TAM)

6. In Vitro Cancer Diagnostics Market Segmentation

  • 6.1. Global In Vitro Cancer Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Kits
  • Instruments
  • Reagents
  • Software
  • Consumables
  • 6.2. Global In Vitro Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Polymerase Chain Reaction (PCR)
  • Next-Generation Sequencing (NGS)
  • Fluorescence In Situ Hybridization (FISH)
  • Immunohistochemistry
  • Other Technologies
  • 6.3. Global In Vitro Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Breast Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Prostate Cancer
  • Other Applications
  • 6.4. Global In Vitro Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Diagnostic Laboratories
  • Research Institutes
  • Home Care Settings
  • Other End Users
  • 6.5. Global In Vitro Cancer Diagnostics Market, Sub-Segmentation Of Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Immunoassay Kits
  • Polymerase Chain Reaction (PCR) Kits
  • Enzyme-Linked Immunosorbent Assay (ELISA) Kits
  • Flow Cytometry Kits
  • 6.6. Global In Vitro Cancer Diagnostics Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Polymerase Chain Reaction (PCR) Instruments
  • Sequencers
  • Flow Cytometers
  • Imaging Systems
  • 6.7. Global In Vitro Cancer Diagnostics Market, Sub-Segmentation Of Reagents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Enzymes
  • Buffers
  • Probes
  • Stains
  • 6.8. Global In Vitro Cancer Diagnostics Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Data Analysis Software
  • Imaging Software
  • Laboratory Information Management System (LIMS) Software
  • Diagnostic Reporting Software
  • 6.9. Global In Vitro Cancer Diagnostics Market, Sub-Segmentation Of Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Microplates
  • Pipette Tips
  • Tubes
  • Slides

7. In Vitro Cancer Diagnostics Market Regional And Country Analysis

  • 7.1. Global In Vitro Cancer Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global In Vitro Cancer Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific In Vitro Cancer Diagnostics Market

  • 8.1. Asia-Pacific In Vitro Cancer Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific In Vitro Cancer Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific In Vitro Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific In Vitro Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China In Vitro Cancer Diagnostics Market

  • 9.1. China In Vitro Cancer Diagnostics Market Overview
  • 9.2. China In Vitro Cancer Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China In Vitro Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China In Vitro Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India In Vitro Cancer Diagnostics Market

  • 10.1. India In Vitro Cancer Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India In Vitro Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India In Vitro Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan In Vitro Cancer Diagnostics Market

  • 11.1. Japan In Vitro Cancer Diagnostics Market Overview
  • 11.2. Japan In Vitro Cancer Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan In Vitro Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan In Vitro Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia In Vitro Cancer Diagnostics Market

  • 12.1. Australia In Vitro Cancer Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia In Vitro Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia In Vitro Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia In Vitro Cancer Diagnostics Market

  • 13.1. Indonesia In Vitro Cancer Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia In Vitro Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia In Vitro Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea In Vitro Cancer Diagnostics Market

  • 14.1. South Korea In Vitro Cancer Diagnostics Market Overview
  • 14.2. South Korea In Vitro Cancer Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea In Vitro Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea In Vitro Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe In Vitro Cancer Diagnostics Market

  • 15.1. Western Europe In Vitro Cancer Diagnostics Market Overview
  • 15.2. Western Europe In Vitro Cancer Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe In Vitro Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe In Vitro Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK In Vitro Cancer Diagnostics Market

  • 16.1. UK In Vitro Cancer Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK In Vitro Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK In Vitro Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany In Vitro Cancer Diagnostics Market

  • 17.1. Germany In Vitro Cancer Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany In Vitro Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany In Vitro Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France In Vitro Cancer Diagnostics Market

  • 18.1. France In Vitro Cancer Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France In Vitro Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France In Vitro Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy In Vitro Cancer Diagnostics Market

  • 19.1. Italy In Vitro Cancer Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy In Vitro Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy In Vitro Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain In Vitro Cancer Diagnostics Market

  • 20.1. Spain In Vitro Cancer Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain In Vitro Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain In Vitro Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe In Vitro Cancer Diagnostics Market

  • 21.1. Eastern Europe In Vitro Cancer Diagnostics Market Overview
  • 21.2. Eastern Europe In Vitro Cancer Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe In Vitro Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe In Vitro Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia In Vitro Cancer Diagnostics Market

  • 22.1. Russia In Vitro Cancer Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia In Vitro Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia In Vitro Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America In Vitro Cancer Diagnostics Market

  • 23.1. North America In Vitro Cancer Diagnostics Market Overview
  • 23.2. North America In Vitro Cancer Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America In Vitro Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America In Vitro Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA In Vitro Cancer Diagnostics Market

  • 24.1. USA In Vitro Cancer Diagnostics Market Overview
  • 24.2. USA In Vitro Cancer Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA In Vitro Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA In Vitro Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada In Vitro Cancer Diagnostics Market

  • 25.1. Canada In Vitro Cancer Diagnostics Market Overview
  • 25.2. Canada In Vitro Cancer Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada In Vitro Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada In Vitro Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America In Vitro Cancer Diagnostics Market

  • 26.1. South America In Vitro Cancer Diagnostics Market Overview
  • 26.2. South America In Vitro Cancer Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America In Vitro Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America In Vitro Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil In Vitro Cancer Diagnostics Market

  • 27.1. Brazil In Vitro Cancer Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil In Vitro Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil In Vitro Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East In Vitro Cancer Diagnostics Market

  • 28.1. Middle East In Vitro Cancer Diagnostics Market Overview
  • 28.2. Middle East In Vitro Cancer Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East In Vitro Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East In Vitro Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa In Vitro Cancer Diagnostics Market

  • 29.1. Africa In Vitro Cancer Diagnostics Market Overview
  • 29.2. Africa In Vitro Cancer Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa In Vitro Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa In Vitro Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. In Vitro Cancer Diagnostics Market Competitive Landscape And Company Profiles

  • 30.1. In Vitro Cancer Diagnostics Market Competitive Landscape
  • 30.2. In Vitro Cancer Diagnostics Market Company Profiles
    • 30.2.1. F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Thermo Fisher Scientific Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis

31. In Vitro Cancer Diagnostics Market Other Major And Innovative Companies

  • 31.1. Illumina Inc
  • 31.2. Hologic Inc
  • 31.3. Qiagen N.V
  • 31.4. Bio-Rad Laboratories Inc
  • 31.5. Agilent Technologies
  • 31.6. Becton Dickinson and Company (BD)
  • 31.7. Sysmex Corporation
  • 31.8. LabCorp Holding Corp.
  • 31.9. Guardant Health
  • 31.10. Quest Diagnostics
  • 31.11. Exact Sciences
  • 31.12. Myriad Genetics Inc
  • 31.13. Natera Inc.
  • 31.14. NeoGenomics Laboratories
  • 31.15. NanoString Technologies Inc

32. Global In Vitro Cancer Diagnostics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The In Vitro Cancer Diagnostics Market

34. Recent Developments In The In Vitro Cancer Diagnostics Market

35. In Vitro Cancer Diagnostics Market High Potential Countries, Segments and Strategies

  • 35.1 In Vitro Cancer Diagnostics Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 In Vitro Cancer Diagnostics Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 In Vitro Cancer Diagnostics Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer